MMRSA Guide
Microscopic illustration of MRSA (Staphylococcus aureus) bacteria
Reference · Treatment

Treating MRSA bloodstream infection

MRSA bacteraemia is the most dangerous form of the infection. Treatment combines prompt intravenous antibiotics, a search for where the bacteria are coming from, and weeks of therapy guided by repeat blood cultures.

Reviewed and updated by the MRSA Guide editorial team.

How MRSA reaches the bloodstream

The commonest routes are an intravenous line or dialysis catheter, an untreated skin or wound infection, bone and joint infection, pneumonia, and injecting drug use. Once in the blood, MRSA can settle on heart valves, vertebrae, joints and prosthetic material, creating secondary foci that dictate how long treatment must run. Background on the condition itself is on the MRSA bacteremia page.

First-line therapy

Treatment starts immediately with intravenous vancomycin or daptomycin. Vancomycin dosing is guided by therapeutic drug monitoring; daptomycin is given once daily with weekly creatine kinase checks. Daptomycin must never be used for MRSA pneumonia because lung surfactant inactivates it.

  • Repeat blood cultures every 48–72 hours until negative
  • Echocardiography in every case of S. aureus bacteraemia
  • Remove infected lines and drain any collection promptly
  • Infectious-diseases consultation, which independently improves survival

Persistent or complicated infection

Cultures still positive after 72 hours mean the source has not been controlled. Re-image, remove devices, and escalate: high-dose daptomycin (8–10 mg/kg) combined with ceftaroline is the most widely used salvage regimen. Rifampicin is added only for infection on prosthetic material, never alone and never before the blood has cleared. Untreated, bloodstream infection progresses to sepsis.

Every MRSA antibiotic listed and described

Frequently asked questions

What is the first-line treatment for MRSA bacteraemia?
Intravenous vancomycin, dosed to an AUC24/MIC target of 400–600, or intravenous daptomycin at 6–10 mg/kg once daily. Daptomycin is preferred when the vancomycin MIC is raised, kidney function is a concern, or the patient has failed vancomycin. Blood cultures are repeated every 48–72 hours until they are negative.
How long is treatment for MRSA in the blood?
Uncomplicated bacteraemia — a removable source, negative cultures within 72 hours, no endocarditis or implants, and fever settling within 72 hours — is treated for at least 14 days from the first negative culture. Complicated bacteraemia, endocarditis, bone infection or an unremovable device requires 4–6 weeks or longer.
Why does everyone with MRSA in the blood need an echocardiogram?
S. aureus seeds heart valves readily, and endocarditis changes both the treatment length and the need for surgery. Guidelines recommend echocardiography for all S. aureus bacteraemia, with transoesophageal imaging when the transthoracic study is inconclusive or the risk is high.
What is persistent MRSA bacteraemia?
Blood cultures that stay positive beyond 72 hours of appropriate therapy. It signals an undrained focus, an infected device, or endocarditis. The response is to hunt for and remove the source, re-image, and escalate therapy — commonly high-dose daptomycin combined with ceftaroline.
Which antibiotics do not work for MRSA?
All the ordinary beta-lactams: penicillin, amoxicillin, flucloxacillin, cefalexin, ceftriaxone and co-amoxiclav. The mecA gene produces PBP2a, which these drugs cannot bind. Ceftaroline is the exception — a cephalosporin that does bind PBP2a.
What is the mortality of MRSA bloodstream infection?
Reported 30-day mortality is roughly 15–30%, and higher in older patients, those with endocarditis, and where source control is delayed. Prompt effective antibiotics, removal of infected lines and specialist infection input all improve survival.
References
  1. Infectious Diseases Society of America. Clinical practice guidelines for the treatment of MRSA infections (2011)
  2. American Journal of Health-System Pharmacy. Therapeutic monitoring of vancomycin for serious MRSA infections: revised consensus guideline (2020)
  3. New England Journal of Medicine. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus (2006)
  4. American Heart Association. Infective endocarditis in adults: diagnosis, antimicrobial therapy and management of complications (2015)

Treatment hub

How MRSA treatment is chosen by site and severity.

Skin & soft-tissue infection

Drainage first, then which oral antibiotics and for how long.

Invasive wound infection

Surgical and traumatic wounds, debridement and source control.

Decolonisation

Mupirocin and chlorhexidine protocols to clear carriage.

Every MRSA antibiotic

All 12 drugs used against MRSA, with route and role.

Related